These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Willingness-to-pay for benefits associated with basal insulin treatment of type 2 diabetes.
    Author: Jendle J, Ridderstråle M, Torfvitt O, Ericsson A, Larsen S.
    Journal: J Med Econ; 2012; 15(2):261-3. PubMed ID: 22142237.
    Abstract:
    Data from a 20-week trial comparing insulin detemir and neutral protamine Hagedorn (NPH) insulin in insulin-naïve people with type 2 diabetes were analyzed using willingness-to-pay (WTP) data, a proxy for patient preference. The advantages of insulin detemir relative to NPH insulin with respect to a lower hypoglycemia rate and less weight gain were associated with a value of €27.87 per month.
    [Abstract] [Full Text] [Related] [New Search]